{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:43:36Z","timestamp":1790811816835,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00001"],"award-info":[{"award-number":["75N92021D00001"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00002"],"award-info":[{"award-number":["75N92021D00002"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00003"],"award-info":[{"award-number":["75N92021D00003"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00004"],"award-info":[{"award-number":["75N92021D00004"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00005"],"award-info":[{"award-number":["75N92021D00005"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL136390-01"],"award-info":[{"award-number":["1R01HL136390-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ahj.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T11:32:37Z","timestamp":1673609557000},"page":"157-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Evaluation of the association between circulating IL-1\u03b2 and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-6519","authenticated-orcid":false,"given":"Sofia E.","family":"Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Parizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ermakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themistocles","family":"Assimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Stefanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco V.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.01.010_bib0001","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ahj.2023.01.010_bib0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2023.01.010_bib0004","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.010_bib0005","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","volume":"236","author":"Toldo","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ahj.2023.01.010_bib0006","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 blockade in cardiovascular diseases: a clinical update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0007","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2023.01.010_bib0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0009","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1540-8167.2010.01774.x","article-title":"Update on the association of inflammation and atrial fibrillation","volume":"21","author":"Patel","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0010","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0011","doi-asserted-by":"crossref","first-page":"25025","DOI":"10.18632\/aging.203754","article-title":"Serum levels of proinflammatory cytokines and selected bioelements in perimenopausal women with regard to body mass index [Internet]","volume":"13","author":"Cybulska","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.ahj.2023.01.010_bib0012","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1152\/ajpendo.00070.2021","article-title":"Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity","volume":"321","author":"Kunz","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ahj.2023.01.010_bib0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2023.01.010_bib0014","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2023.01.010_bib0015","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.01.010_bib0016","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/heartjnl-2013-303798","article-title":"Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study","volume":"99","author":"Perez","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2023.01.010_bib0017","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/eurheartj\/ehz003","article-title":"Body composition and atrial fibrillation: a Mendelian randomization study","volume":"40","author":"Tikkanen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0018","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/oby.20706","article-title":"Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. a Danish cohort study","volume":"22","author":"Frost","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.ahj.2023.01.010_bib0019","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/eurheartj\/ehv423","article-title":"Lean body mass and risk of incident atrial fibrillation in post-menopausal women","volume":"37","author":"Azarbal","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2010.02.066","article-title":"Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population","volume":"56","author":"Marott","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0021","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehq146","article-title":"A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women","volume":"31","author":"Conen","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.010_bib0023","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.010_bib0024","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ahj.2015.09.018","article-title":"Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation [Internet]","volume":"170","author":"Aulin","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41525-019-0097-4","article-title":"A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity","volume":"4","author":"Rosa","year":"2019","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.ahj.2023.01.010_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2023.01.010_bib0027","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/jir.2019.0098","article-title":"Increasing level of interleukin-1\u03b2 in epicardial adipose tissue is associated with persistent atrial fibrillation","volume":"40","author":"Liu","year":"2020","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ahj.2023.01.010_bib0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00395-016-0584-z","article-title":"Cross-talk between macrophages and atrial myocytes in atrial fibrillation","volume":"111","author":"Sun","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196709","article-title":"Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation","volume":"13","author":"Jung","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2023.01.010_bib0030","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cca.2010.07.005","article-title":"Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1","volume":"411","author":"Wang","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ahj.2023.01.010_bib0031","doi-asserted-by":"crossref","unstructured":"A Abbate, GF Wohlford, MG Del Buono, et\u00a0al., Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials, Eur Heart J-Cardiovasc Pharmacother, 8 (5), 2021, 503\u2013510.","DOI":"10.1093\/ehjcvp\/pvab075"},{"key":"10.1016\/j.ahj.2023.01.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2023.01.010_bib0033","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis. Reply","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2023.01.010_bib0034","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S1047-2797(03)00047-4","article-title":"The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures","volume":"13","author":"Langer","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ahj.2023.01.010_bib0036","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2018.12.006","article-title":"Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women","volume":"209","author":"Boursiquot","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0037","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.04.006","article-title":"Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study","volume":"17","author":"Kaplan","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ahj.2023.01.010_bib0038","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/heartjnl-2015-308927","article-title":"The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women","volume":"102","author":"Ermakov","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2023.01.010_bib0039","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/oby.20139","article-title":"The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the Women's Health Initiative Observational Study [Internet]","volume":"22","author":"Khan","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.ahj.2023.01.010_bib0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.010_bib0041","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.010_bib0042","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0043","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ahj.2023.01.010_bib0044","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation [Internet]","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0045","first-page":"126","article-title":"Association of C-reactive protein with cardiovascular outcomes: a mendelian randomization study in the Japanese population","volume":"35","author":"Cao","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.ahj.2023.01.010_bib0046","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.athoracsur.2020.04.123","article-title":"Interleukin-6 receptor Asp358 A>C polymorphism is associated with postoperative atrial fibrillation","volume":"111","author":"Wu","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2023.01.010_bib0047","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2020.03.053","article-title":"Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: a two-sample Mendelian randomization study","volume":"313","author":"Yuan","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.01.010_bib0048","first-page":"1976","article-title":"Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation","volume":"124","author":"Deng","year":"2011","journal-title":"Chin Med J"},{"key":"10.1016\/j.ahj.2023.01.010_bib0049","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/07853890.2015.1042030","article-title":"Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: a novel potential therapeutic target?","volume":"47","author":"Ren","year":"2015","journal-title":"Ann Med"},{"key":"10.1016\/j.ahj.2023.01.010_bib0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","article-title":"Role of inflammation and oxidative stress in atrial fibrillation [Internet]","volume":"7","author":"Li","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2023.01.010_bib0051","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/europace\/eun111","article-title":"Source of inflammatory markers in patients with atrial fibrillation","volume":"10","author":"Liuba","year":"2008","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ahj.2023.01.010_bib0052","first-page":"11","volume":"10","author":"Pratesi","year":"2013","journal-title":"Skeletal muscle: an endocrine organ, Clin Cases Min Bone Metab"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032300011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032300011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:48Z","timestamp":1757571048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032300011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"alternative-id":["S000287032300011X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the association between circulating IL-1\u03b2 and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}